- After the Republican Party's disastrous midterm defeat, can Trump still maintain his tariff policy? Don’t expect any changes before 2029.
- DSA’s Adrian Wall and Former CFTC Chair Chris Giancarlo Discuss Future of U.S. Crypto Regulation at Strobe Summit
- Genpact forecasts 2026 revenue growth of at least 7%
- INSIGHT ENTERPRISES INC <NSIT.O>: RAYMOND JAMES RAISES TARGET PRICE TO $185 FROM $175
- Bernstein Comments on Datadog (DDOG.US) Q3 Financial Report: Strong Performance but Guidance "Not Surprising", Lowers AI Business Revenue Expectations
- S&P evaporates 2.8 trillion in a single day, BTIG warns: This is not the bottom, the real sell-off has just begun
- Bernstein comments on Datadog (DDOG.US) Q3 earnings: strong performance but guidance "not surprising," lowers AI business revenue expectations
- Orchestra BioMed: Proceeds Will Also Go Toward Research, Clinical Development of Other Product Candidates >OBIO
- Mirrabooka Flags Attractive Small- and Mid-Cap Valuations at AGM
- ENOVIS CORPORATION <ENOV.N>: NEEDHAM RAISES TARGET PRICE TO $38 FROM $34
- Orchestra BioMed Expects Gross Proceeds of $75.0M From Offering >OBIO
- CANADIAN NATURAL RESOURCES LTD <CNQ.TO>: NATIONAL BANK OF CANADA RAISES TARGET PRICE TO C$87 FROM C$86
- Brent crude oil futures main contract surpasses $100 per barrel, up 0.94% intraday
- Oil prices are expected to plunge this week, with both Brent and WTI projected to fall by more than 12%.
- Orchestra BioMed Expects Offering to Close Nov. 9 >OBIO
- Spot gold falls below the $4,050 mark, down 0.97% on the day
- Spot gold falls 1% to $4,047.84, COMEX gold drops 1.35%
- QUEBECOR INC. <QBRb.TO>: NATIONAL BANK OF CANADA RAISES TARGET PRICE TO C$80 FROM C$71
- CS Wind Q3 Operating Profit Rises 22.8% Year Over Year
- Blue Wave Kicks the AI Bull Market Off Its Feet: Nasdaq Plunges 5.5% Into Correction — Wall Street Went From Celebration to Doubt in Just 24 Hours. Click to See the Full List of Potential Beneficiaries!
- ROYAL GOLD, INC. <RGLD.O>: NATIONAL BANK OF CANADA RAISES TARGET PRICE TO $300 FROM $285
- Sigma Healthcare's Chemist Warehouse Opens First English Store in London
- Orchestra BioMed Underwriters Have Option to Buy Additional 2.25M Shrs >OBIO
- Orchestra BioMed Prices Offering of 15M Shares at $5.00 Each >OBIO
- AFIC Hosts Information Meeting on Financial Performance and Investments
- Orchestra BioMed Prices $75 Million Public Offering at $5 per Share
- STEVEN MADDEN, LTD. <SHOO.O>: NEEDHAM CUTS TARGET PRICE TO $45 FROM $52
- MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC. <MTSI.O>: SUSQUEHANNA CUTS TARGET PRICE TO $220 FROM $300
- Kioxia six-month operating profit rises to JPY 3.26 trillion
- Careplus proposes 1-for-2 rights issue to raise up to RM 29.78 million
- SM ENERGY CO <SM.N>: SUSQUEHANNA CUTS TARGET PRICE TO $33 FROM $44
- Airbnb Publishes Q3 2026 Earnings Call Transcript
- Doubleview Gold Raises $3.23 Million in First Tranche of Flow-Through Private Placement
- CARDINAL HEALTH, INC. <CAH.N>: LEERINK PARTNERS RAISES TARGET PRICE TO $330.00 FROM $292.00
- MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC. <MTSI.O>: NEEDHAM CUTS TARGET PRICE TO $300 FROM $410
- Sigma Healthcare joins suppliers at 2026 event in Margaret Court Arena
- AIRBNB, INC. : PIPER SANDLER RAISES TARGET PRICE TO $180 FROM $170
- IRHYTHM HOLDINGS, INC <IRTC.O>: PIPER SANDLER CUTS TARGET PRICE TO $150 FROM $160
- A-Rank Publishes 2026 Annual Report
- A-Rank Seeks Shareholder Approval to Renew Related-Party Transaction Mandate
- A-Rank Publishes 2026 Corporate Governance Report
- Mitra Komunikasi Nusantara Says No Undisclosed Material Information Behind Share Volatility
- Updated version 1 - SoftBank’s credit risk soars to a 4-year high as market turbulence is driven by concerns over artificial intelligence
- GFC Life Science's Kang Hee Cheol, Affiliates Raise Combined Stake to 37.72%
- Bernstein Comments on Coherent (COHR.US) Q1 Results: No Issues with Fundamentals, Focus is on Timing of Realization, Maintains "Outperform" Rating
- Bernstein comments on Coherent (COHR.US) Q1 results: No issues with fundamentals, focus is on timing of realization; maintains "Outperform" rating
- National Development and Reform Commission: This winter’s heating season energy supply will generally meet demand
- Spot gold falls below $4,060 per ounce, down 0.71% on the day
- Samara Asset Group Flags Shrinking Premiums as Risk to Bitcoin Treasury Funding
- EcoCab Plans KRW 1.5 Billion Share Buyback
- Song Sung Geun, Related Parties Raise IL Stake to 21.20% From 21.18%
- Liberty Capital 3Q Rev $267M >GLIBA
- ScanSource Sees FY27 Free Cash Flow at Least $85M >SCSC
- ScanSource Sees FY27 Adjusted Ebitda $175M-$185M >SCSC
- ScanSource Sees FY27 Sales $3.8B-$4B >SCSC
- Dogwood Therapeutics 3Q Rev $100,000 >DWTX
- Construction Partners Sees FY26 Net $141.5M-Net $142.5M >ROAD
- ScanSource 1Q Sales $962.3M >SCSC
- Construction Partners Sees FY27 Rev $4.175B-$4.275B >ROAD
- Construction Partners Sees FY27 Net $170.9M-Net $180.8M >ROAD
- MDU Resources Group Long-term EPS Growth Objective Remains 6%-8% >MDU
- Dogwood Therapeutics 3Q Research and Development Expenses $3.3M >DWTX
- Disc Medicine Plans Bitopertin NDA Resubmission by End of 2026 >IRON
- Construction Partners Sees FY26 Rev $3.66B-$3.68B >ROAD
- Guerrilla RF: Chief Executive Officer Ryan Pratt to Continue as Director >GUER
- MDU Resources Group Backs 2026 EPS 93c-EPS $1 >MDU
- Disc Medicine 3Q Loss $59.5M >IRON
- MDU Resources Group 3Q Adj EPS 8c >MDU
- MDU Resources Group 3Q EPS 7c >MDU
- ScanSource 1Q Net $8.69M >SCSC
- ScanSource 1Q Adj EPS 86c >SCSC
- ScanSource 1Q EPS 42c >SCSC
- Scynexis 3Q Loss $8.46M >SCYX
- Scynexis 3Q Loss/Shr 71c >SCYX
- NexPoint Real Estate Finance 3Q Cash Available for Distribution $14 M, or 60c/Shr
- Holley Sees 2026 Sales $610M-$625M >HLLY
- Holley 3Q Sales $141.6M >HLLY
- Aemetis 3Q Loss/Shr 2c >AMTX
- CRA Intl Raises Quarterly Dividend to 67c Vs. 57c >CRAI
- CRA Intl Raises Dividend to 67c Vs. 57c >CRAI
- USA TODAY Had 3Q Digital Advertising Rev of $75M >TDAY
- Ralph Lauren Expects 3Q Rev to Grow Low- to Mid-Single Digits on Constant Currency Basis, Centered Around 3% to 4% >RL
- Correct: Sabre 3Q Rev $738M >SABR
- USA TODAY 3Q Total Digital Rev of $249.3M >TDAY
- USA TODAY 3Q Same Store Revenues Decreased 5.8% Yr-over-Yr >TDAY
- Ralph Lauren Expects FY27 Constant Currency Rev to Increase Mid- to High-Single Digits to Last Yr on 52-Week Comparable Basis, Now Centered Around 6% to 7% >RL
- Insight Enterprises 3Q Adj EPS $3.59 >NSIT
- Shattuck Labs 3Q Research and Development Expenses $21.6M >STTK
- Sabre 3Q Adj Loss/Shr 17c >SABR
- Novavax 3Q Research and Development Expenses $52M >NVAX
- Ralph Lauren 2Q Same-Store Sales Up 10% >RL
- Ralph Lauren 2Q Rev $2.19B >RL
- Ralph Lauren 2Q Net $296.6M >RL
- Ralph Lauren 2Q Adj EPS $4.64 >RL
- Ralph Lauren 2Q EPS $4.87 >RL
- Dominari Advances $5 Million Buyback With More Than 1.9 Million Shares Repurchased >DOMH
- Portillo's 3Q Same-Restaurant Sales Up 1.4% >PTLO
- Sabre 3Q Loss/Shr 9c >SABR
- Filana Therapeutics 3Q Loss/Shr 22c >FLNA
- Tejon Ranch 3Q EPS 12c >TRC
